For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...

This quarter, Elevance Health grew its revenue by 6.6% year on year, and its $45.44 billion of revenue was in line with Wall Street’s estimates. Looking ahead, sell-side analysts expect revenue to ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $646.73 today based on a ...

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Elevance Health Inc. ELV slipped 2.91% to $390.47 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to ...

Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a ...

UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...